Skip to main content
. Author manuscript; available in PMC: 2011 May 25.
Published in final edited form as: Accid Anal Prev. 2010 May;42(3):852–858. doi: 10.1016/j.aap.2009.07.009

Table 2.

Group comparison of participants’ performance on cognitive and vision measures.

Measure AD (n = 6)


M [SD]
PD (n = 8)


M [SD]
Neurodegenerative
Disease Group
(AD+PD) (n = 14)
M [SD]
Comparison
Group (n = 18)

M [SD]
Far Vision
(LogMAR)
.14 [.08]
p = .001*
−.03 [.09]
p = .96
.04 [.12]
p = .06
−.03 [.10]
Near Vision
(LogMAR)
.15 [.09]
p = .02*
.03 [.04]
p = .28
.08 [.09]
p = .38
.05 [.07]
Contrast Sensitivity 1.45 [.23]
p = .0003*
1.67 [.10]
p = .04*
1.58 [.19]
p = .002*
1.78 [.14]
UFOV 2 178.60 [102.20]
p =.004*
41.63 [40.79]
p = .77
94.31 [96.24]
p = .15
49.83 [72.49]
UFOV 3 363.20 [128.28]
p = .02*
209.00 [134.03]
p = .23
268.31 [148.53]
p = .03*
161.61 [65.89]
UFOV 4 476.60 [39.02]
p = .0002*
321.13 [129.04]
p = .81
380.92 [128.13]
p = .27
333 [107.85]
UFOV Total 1074.60 [215.32]
p = .0001*
590.38 [283.98]
p = .82
776.61 [350.17]
p = .07
567.89 [209.54]
COGSTAT 298.00 [78.43]
p = .02*
368.21 [55.99]
p = .09
338.13 [73.17]
p = .004*
405.38 [47.22]
MMSE 24.50 [4.42]
p = .06
28.5 [1.60]
p = .60
26.79 [3.62]
p = .07
28.78 [1.06]
*

Denotes significant differences between comparisons and each of the disease groups.